Search - tctmd.com

Presenter: Philippe Genereux, Susheel Kodali, Martin Leon, Philip Green, Benoit Daneault, Jean-Michel Paradis, Isaac George, Ajay Kirtane, Rebecca Hahn, Craig Smith, Mathew Williams

January 31, 2013

Presentation TCT 2012

Keynote Lecture 3: The U.S. Commercial TAVR Site Activation Program: Update, Analysis, Report Card, and Future Expectations

Presenter: Susheel Kodali

October 26, 2012

Presentation TCT 2012

State-of-the-Field Keynote: Emerging Opportunities for Future TAVR Development: Stroke, Paravalvular Leaks, and Beyond

Presenter: Susheel Kodali

October 23, 2012

News Conference News TCT 2012

PARTNER Shows Continued Benefits of TAVR, but STACCATO Introduces Questions About Transapical Use

October 23, 2012

News Conference News TCT 2012

PARTNER Analyses Provide Important Insights into TAVR

October 22, 2012

Presentation ACC 2012

Late (≥ 2 year) Clinical and Echocardiographic Outcomes after Transcatheter vs. Surgical Aortic Valve Replacement: Results from the High-Risk Cohort of The PARTNER Trial

Presenter: Susheel K. Kodali

March 26, 2012

Advertisement

VIVID登记处：瓣中瓣TAVR的益处取决于手术后退化生物瓣膜的大小、状态

VIVID Registry: Benefit of Valve-in-Valve TAVR Depends on Size, Status of Failed Surgical Bioprosthesis

Registro VIVID: El Beneficio de la TAVR Válvula dentro de Otra Válvula Depende del Tamaño y del Estatus de Bioprótesis Quirúrgica Fallida

Introduction to the US FDA-Approved Sentinel TAVR Safety and Efficacy Study

New Iteration of Sapien Device Associated with Low Rates of Early Mortality, Stroke

Over the Long Haul, TAVR Appears Better Than Surgery for Women

A la Larga, la TAVR parece Mejor que la Cirugía en Mujeres

PARTNER: Lung Disease No Barrier to TAVR But Increases Mortality Risk

PARTNER: La Enfermedad Pulmonar No es Barrera para la TAVR pero Aumenta el Riesgo de Mortalidad

TAVR-Associated Aortic Root Rupture Hazardous but Predictable

Patients Who Need Valve-in-Valve After TAVR See Poorer Outcomes

Los Pacientes que precisan una Válvula dentro de Otra Válvula tras una TAVR tienen Peores Resultados

PARTNER Substudy Looks at Echocardiographic Differences Between TAVR, Surgery

El Subestudio PARTNER Analiza las Direrencias Ecocardiográficas existentes entre la TAVR y la Cirugía

Incidence and Impact of Acquired Thrombocytopenia on Bleeding Events and Mortality after Transcatheter Aortic Valve Replacement (TAVR)

Keynote Lecture 3: The U.S. Commercial TAVR Site Activation Program: Update, Analysis, Report Card, and Future Expectations

State-of-the-Field Keynote: Emerging Opportunities for Future TAVR Development: Stroke, Paravalvular Leaks, and Beyond

PARTNER Shows Continued Benefits of TAVR, but STACCATO Introduces Questions About Transapical Use

PARTNER Analyses Provide Important Insights into TAVR

Late (≥ 2 year) Clinical and Echocardiographic Outcomes after Transcatheter vs. Surgical Aortic Valve Replacement: Results from the High-Risk Cohort of The PARTNER Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content